Table 2.

Relationship between miR-193a expression and clinicopathological features of NSCLC patients.

Characteristics	n	miR-193a expression		P
		Low expression (n = 32)	High expression (n = 31)
Age (year)
<60	36	19	17	0.801
≥60	27	13	14
Gender
Male	39	18	21	0.439
Female	24	14	10
TNM stage
I–II	38	9	29	<0.001
III–IV	25	23	2
Smoking history
Smoking	35	20	15	0.315
Non-smoking	28	12	16
Differentiation degree
High and middle differentiation	40	16	24	0.036
Poor differentiation	23	16	7
Size of lesions (cm)
≥5	40	23	17	0.196
<5	23	9	14

miR-193a microRNA-193a; TNM stage tumor-node-metastasis stage.

The data in this table was enumeration data, and verified by chi-square test.